Shorter radiation schedule after mastectomy for high-risk breast cancer
Part of Cancer, Skin clinical trials.
This trial compares a shorter radiation plan to a standard longer plan after mastectomy for people considered high risk. It may help reduce treatment time while still trying to prevent breast-cancer recurrence.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 75 years old
- You had a mastectomy and lymph node removal (more than 10 nodes) and your surgery margins were clear
- Your cancer is invasive breast cancer with certain high-risk features (for example: age under 40, grade 3, lymph/vascular invasion, hormone-receptor negative or HER2 positive, or more affected lymph nodes)
- There is no spread to distant organs, and no spread to supraclavicular or internal mammary lymph nodes
- You can receive radiotherapy (radiation) and have no major health problems that would make radiation unsafe; your energy level score (ECOG) is 0 to 1
- You have not had chemotherapy before surgery (no neoadjuvant chemo) and you can and will sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a shorter, higher-dose radiation schedule (hypofractionation) for women who have had a mastectomy and immediate breast reconstruction with implants. The goal is to see if this approach works as well as standard radiation while possibly being more convenient and causing fewer side effects.
This study compares two radiation schedules for breast cancer patients at high risk of cancer returning in lymph nodes. Both use modern radiation therapy, but one delivers treatment faster (ultra-hypofractionated) while the other uses a more moderate schedule. The goal is to see which approach works better with fewer side effects.
This Phase 3 trial tests whether a shorter, more focused radiation treatment to the regional lymph nodes works as well as the current standard approach for certain breast cancers. It may help patients by potentially improving treatment efficiency while keeping cancer control effective.
This trial compares standard radiation therapy to a shorter course (hypofractionated) for women who have had a mastectomy with implant reconstruction. The goal is to see if the shorter schedule works as well while possibly reducing side effects for the reconstructed breast.
This Phase 3 trial compares two radiation treatment schedules after mastectomy in people who had breast reconstruction. It aims to see which schedule works better and is easier to tolerate for preventing cancer from coming back.
This trial studies a radiation schedule given after breast cancer surgery when your breast was rebuilt right away with a prosthesis (implant or similar). It aims to see whether this “hypofractionated” (fewer, larger treatment sessions) radiation approach is appropriate for patients who need additional (adjuvant) radiation to reduce recurrence risk.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.